At 89, Agboola Anifowose is living proof that sickle cell disease does not have to define the length or possibilities of a life, and his extraordinary journey from Nigeria to America and back provides the heart of this edition.
His remarkable claim that gallbladder surgery dramatically reduced his sickle cell crises opens an intriguing medical debate over whether there may be more to the connection than coincidence.
The edition explores the wider implications of genotype, from Anifowose’s family experience to the urgent case for genotype verification and informed reproductive decisions.
Nigeria’s return to the global Sickle Cell Congress after 40 years provides another major focus, highlighting the country’s burden, its growing leadership in advocacy and research, and the landmark bone-marrow transplant achieved locally.
We look at the rapidly changing treatment landscape, including gene therapy and emerging genetic technologies that are reshaping expectations for inherited disorders.
Beyond SCD, the edition broadens the inherited-blood-disorder conversation with International Thalassemia Day and the global campaign for better awareness, screening, treatment and research.
From Anifowose’s 89-year survival story to the experiences of Warriors such as Kye Gbangbola and Agnes Anifowose-Odunsi, this is an edition about survival, family, science and the continuing fight to change what sickle cell disease means for those who live with it.